0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Special Feature |

Image of the Month—Diagnosis FREE

[+] Author Affiliations

SECTION EDITOR: CARL E. BREDENBERG, MD

More Author Information
Arch Surg. 2012;147(10):974. doi:10.1001/archsurg.147.10.974.
Text Size: A A A
Published online

Slides of pathologic samples from the initial biopsy specimen confirmed the diagnosis of metastatic HCC. Immunohistochemical staining for HepPar-1, pancytokeratin, and PIN4 was positive, while staining for PSA, PSMA, P50IS, S-100 protein, and HMB-45 expression was negative. Given the patient's poor performance status and the location of the metastatic disease, surgery was not considered an option. The patient was started on a regimen of sorafenib, 400 mg twice daily, but failed to tolerate this therapy because of hand-foot syndrome. The patient was treated with palliative external beam radiotherapy of 4 Gy (to convert gray to rad, multiply by 100) for 5 fractions, followed by 2 Gy for 15 fractions, for a total of 50 Gy to the pelvic mass. Unfortunately, the patient died 3 months after the conclusion of radiotherapy.

Liver transplant is the preferred treatment for patients with small HCC and established liver cirrhosis. Disease recurrence in the setting of immunosuppression is, however, a major problem and remains the rate-limiting factor for long-term survival. The most common sites of recurrence include the liver graft, lung, and bone. Other possible sites include the abdominal lymph nodes, adrenal glands, and peritoneum.1,2 The patient we describe likely had a “drop” peritoneal recurrence in the cul-de-sac between the prostate and rectum, which subsequently invaded both structures.

Although most patients experience recurrence of HCC in the first 2 years after transplant, late recurrences are possible even years following transplant. In a series of 57 patients with recurrent HCC after liver transplant, 6 patients (11%) experienced recurrence of HCC after 4 or more years.1 Tumor factors associated with late recurrence were small tumor size, well to moderate differentiation, and a history of hepatitis C or alcoholism rather than hepatitis B or cryptogenic cirrhosis. A separate study reported that 69% of recurrences were within the first 2 years and 21% after 3 years.2 Similarly, late recurrence was more common among patients who received a transplant when they had low-stage disease and well-differentiated tumors. Intrahepatic and extrahepatic late recurrences have been documented equally.

Management of recurrent HCC can be difficult and therefore is most appropriately handled in a multidisciplinary setting. Surgical salvage, when feasible, can offer a chance for long-term survival ranging between 27% and 88%.14 Surgical management of intrahepatic recurrence can include resection, ablation, or a second transplant in appropriately selected patients. Other therapeutic options for intrahepatic recurrence include percutaneous ablation or intra-arterial therapy, such as transarterial chemoembolization. Molecular targeted therapy with sorafenib is a systemic option for patients with advanced disease. Finally, radiotherapy—as in the current case—may be helpful to palliate symptoms and retard progression of disease, but its ability to prolong survival in patients with extrahepatic HCC recurrence remains ill defined.

Return to Quiz Case.

Submissions

Due to the overwhelmingly positive response to the Image of the Month, the Archives of Surgery has temporarily discontinued accepting submissions for this feature. Requests for submissions will resume in April 2013. Thank you.

Correspondence: Timothy M. Pawlik, MD, MPH, PhD, Department of Surgery, The Johns Hopkins Hospital, 600 N Wolfe St, Blalock 288, Baltimore, MD 21287 (tpawlik1@jhmi.edu).

Accepted for Publication: October 5, 2011.

Author Contributions:Study concept and design: Kneuertz, Malla, Cosgrove, Kamel, Cameron, and Pawlik. Acquisition of data: Kneuertz, Malla, Kamel, Geschwind, and Pawlik. Analysis and interpretation of data: Malla, Herman, Kamel, and Geschwind. Drafting of the manuscript: Kneuertz, Malla, Herman, Kamel, Cameron, and Pawlik. Critical revision of the manuscript for important intellectual content: Kneuertz, Cosgrove, Herman, Kamel, Geschwind, and Pawlik. Statistical analysis: Malla, Kamel, and Geschwind. Obtained funding: Geschwind. Administrative, technical, and material support: Kneuertz and Pawlik. Study supervision: Kamel, Cameron, and Pawlik.

Financial Disclosure: None reported.

Roayaie S, Schwartz JD, Sung MW,  et al.  Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis.  Liver Transpl. 2004;10(4):534-540
PubMed   |  Link to Article
Schlitt HJ, Neipp M, Weimann A,  et al.  Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation.  J Clin Oncol. 1999;17(1):324-331
PubMed
Taketomi A, Fukuhara T, Morita K,  et al.  Improved results of a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation.  Ann Surg Oncol. 2010;17(9):2283-2289
PubMed   |  Link to Article
Valdivieso A, Bustamante J, Gastaca M,  et al.  Management of hepatocellular carcinoma recurrence after liver transplantation.  Transplant Proc. 2010;42(2):660-662
PubMed   |  Link to Article

Figures

Tables

References

Roayaie S, Schwartz JD, Sung MW,  et al.  Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis.  Liver Transpl. 2004;10(4):534-540
PubMed   |  Link to Article
Schlitt HJ, Neipp M, Weimann A,  et al.  Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation.  J Clin Oncol. 1999;17(1):324-331
PubMed
Taketomi A, Fukuhara T, Morita K,  et al.  Improved results of a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation.  Ann Surg Oncol. 2010;17(9):2283-2289
PubMed   |  Link to Article
Valdivieso A, Bustamante J, Gastaca M,  et al.  Management of hepatocellular carcinoma recurrence after liver transplantation.  Transplant Proc. 2010;42(2):660-662
PubMed   |  Link to Article

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles